Latest Breaking News On - தடுப்பு மருந்துகள் பணி - Page 3 : vimarsana.com

Date Time Alternating vaccines trial expands to include two additional vaccines Experts from the University of Nottingham are looking for people who have had their first Covid-19 vaccination in the past 8-12 weeks, to take part in an extended study investigating alternating doses of two new approved vaccines. Researchers who were part of the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AztraZeneca vaccine and the Pfizer vaccine, have today announced an extension to this programme, to include the Moderna and Novavax vaccines in a new study. The trial is led by the University of Oxford, run by the National Immunisation Schedule Evaluation Consortium (NISEC), and backed through funding from the Vaccines Task Force and the Coalition for Epidemic Preparedness Innovations.

United kingdomMatthew snapeVaccines taskUniversity of oxfordUniversity of nottinghamNational immunisation schedule evaluation consortiumCoalition for epidemic preparedness innovationsVaccines taskforceEpidemic preparednessCripps health centreUniversity parkAssociate professorChief investigatorUniversity of oxfordImmune responseClinical trials